Search hospitals > California > Burbank

Providence Saint Joseph Medical Center - Burbank

Claim this profile
Burbank, California 91505
Global Leader in Lung Cancer
Global Leader in Lymphoma
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Mixed-Cell Lymphoma
97 reported clinical trials
1 medical researcher
Photo of Providence Saint Joseph Medical Center - Burbank in BurbankPhoto of Providence Saint Joseph Medical Center - Burbank in BurbankPhoto of Providence Saint Joseph Medical Center - Burbank in Burbank

Summary

Providence Saint Joseph Medical Center - Burbank is a medical facility located in Burbank, California. This center is recognized for care of Lung Cancer, Lymphoma, Breast Cancer, Pancreatic Cancer, Mixed-Cell Lymphoma and other specialties. Providence Saint Joseph Medical Center - Burbank is involved with conducting 97 clinical trials across 108 conditions. There are 1 research doctors associated with this hospital, such as Karlton Wong.

Area of expertise

1Lung Cancer
Global Leader
Providence Saint Joseph Medical Center - Burbank has run 12 trials for Lung Cancer. Some of their research focus areas include:
Stage III
HER2 negative
Stage II
2Lymphoma
Global Leader
Providence Saint Joseph Medical Center - Burbank has run 11 trials for Lymphoma. Some of their research focus areas include:
low tumor burden
Stage II
Stage III

Top PIs

Karlton WongProvidence St Joseph Medical Center13 years of reported clinical research
Studies Central Nervous System Hodgkin Lymphoma
Studies Peripheral T-Cell Lymphoma
2 reported clinical trials
2 drugs studied

Clinical Trials running at Providence Saint Joseph Medical Center - Burbank

Bladder Cancer
Transitional Cell Carcinoma
Hospital Acquired Infections
Central Line Bloodstream Infection
Image of trial facility.

Disitamab Vedotin + Pembrolizumab vs Chemotherapy

for Bladder Cancer

This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than platinum-containing chemotherapy to treat patients with UC. This study will also test what side effects happen when participants take these drugs together. A side effect is anything a drug does to the body besides treating the disease. Participants in this study will have cancer that has spread through the body (metastatic) or spread near where it started (locally advanced). In this study, there are 2 different groups. Participants will be assigned to a group randomly. Participants in the disitamab vedotin arm will get the study drug disitamab vedotin once every two weeks and pembrolizumab once every 6 weeks. Participants in the standard of care arm will get gemcitabine once a week for 2 weeks with either cisplatin or carboplatin once every 3 weeks.
Recruiting2 awards Phase 3

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Providence Saint Joseph Medical Center - Burbank?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security